Abstract
We report IgG anti-spike levels up to 3 months after vaccination with 2 doses of BNT162b2 mRNA vaccine in healthcare workers (HCW). The antibody response was significantly stronger in previously infected vaccinated HCW compared to uninfected HCW, and stronger after vaccination compared to (mostly) mild natural infection.
Keywords: COVID-19; COVID-19 testing; IgG; Immunoassay; SARS-CoV-2; Spike; Vaccination.
All Keywords
【저자키워드】 COVID-19, SARS-CoV-2, IgG, vaccination, spike, immunoassay, COVID-19 testing, 【초록키워드】 vaccination, mRNA vaccine, Antibody Response, healthcare worker, Mild, natural infection, Anti-spike, dose, HCW, uninfected, significantly, of BNT162b2, 【제목키워드】 vaccination, healthcare worker, BNT162b2, anti-spike antibody,
【저자키워드】 COVID-19, SARS-CoV-2, IgG, vaccination, spike, immunoassay, COVID-19 testing, 【초록키워드】 vaccination, mRNA vaccine, Antibody Response, healthcare worker, Mild, natural infection, Anti-spike, dose, HCW, uninfected, significantly, of BNT162b2, 【제목키워드】 vaccination, healthcare worker, BNT162b2, anti-spike antibody,
{{{ 추상적인 }}}
우리는 의료 종사자(HCW)에서 BNT162b2 mRNA 백신 2회 접종으로 백신 접종 후 최대 3개월까지 IgG 안티 스파이크 수준을 보고합니다. 항체 반응은 감염되지 않은 HCW에 비해 이전에 감염된 백신을 접종한 HCW에서 유의하게 더 강했고 (대부분) 가벼운 자연 감염과 비교하여 백신 접종 후 더 강력했습니다.
{{ 키워드: }} 코로나19; 코로나19 검사; IgG; 면역분석; 사스 코로나바이러스 2; 스파이크; 백신 접종.